Anthony P. Jansz
Direktor/Vorstandsmitglied bei The Medical Finance Co.
Profil
Anthony P.
Jansz is currently a Director at The Medical Finance Co. Prior to this, he was a Director at EnteroMedics, Inc. from 2015 to 2016.
He was also a Managing Director at The Carlyle Group, Inc. from 2005 to 2005.
Additionally, he served as Chairman at The Australian Institute of Weight Control in 2011.
Aktive Positionen von Anthony P. Jansz
| Unternehmen | Position | Beginn |
|---|---|---|
| The Medical Finance Co. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Anthony P. Jansz
| Unternehmen | Position | Ende |
|---|---|---|
EnteroMedics, Inc.
 EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Direktor/Vorstandsmitglied | 12.08.2016 |
| The Australian Institute of Weight Control | Vorsitzender | 01.03.2011 |
| THE CARLYLE GROUP INC. | Corporate Officer/Principal | 01.01.2005 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THE CARLYLE GROUP INC. | Finance |
| Private Unternehmen | 3 |
|---|---|
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
| The Australian Institute of Weight Control | |
| The Medical Finance Co. |
